Scholarlink

Background <p>Many variables may affect approaches of psychiatrists to methamphetamine-associated psychotic disorder (MAP) treatment. This study was aimed to reach adult psychiatrists actively practicing in Turkey through an internet-based survey and to determine their practices and attitudes to MAP treatment.</p> Methods <p>In this internet-based study, participants were divided into three groups based on their answers: Those who do not follow-up any MAP patient were group 1 (<i>n</i> = 78), partially involved in the treatment process of at least one patient diagnosed with MAP were group 2 (<i>n</i> = 128), completely involved in the treatment process of at least one patient diagnosed with MAP were group 3 (<i>n</i> = 202).</p> Results <p>Psychotropic preferences in insomnia (<i>p</i> &lt; 0.001), typical oral antipsychotic choice (<i>p</i> &lt; 0.001), preferred doses of olanzapine/risperidone/aripiprazole/amisulpride for maintenance treatment (<i>p</i> &lt; 0.001), long-acting injectable antipsychotic use practices (<i>p</i> &lt; 0.001), non-antipsychotic psychotropic use characteristics (<i>p</i> &lt; 0.001), extrapyramidal system side effect experiences (<i>p</i> &lt; 0.001), delirium and life-threatening situations encounter rates (<i>p</i> &lt; 0.001) were significantly different between group 2 and group 3. While the duration of maintenance with antipsychotics in the first MAP episode was similar between group 2 and group 3 (<i>p</i> = 0.254), it was different in the second and subsequent MAP episodes (<i>p</i> &lt; 0.05). A binary logistic regression model containing the experiences of long-acting injectable antipsychotic use, extrapyramidal system side effect, and delirium was created (overall <i>p</i> &lt; 0.001, Nagelkerke R<sup>2</sup> = 0.435; Hosmer and Lemeshow test <i>p</i> = 0.203).</p> Conclusions <p>This first study in the field, which examines the current issue in detail, reveals that there are many factors that seriously affect psychiatrists' approaches to MAP treatment in Turkey.</p> Trial registration <p>This study was approved by the Ethics Committee of the Fırat University (Date: 14/09/2023; Number: 2023/12–12).</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Practices and attitudes of adult psychiatrists regarding methamphetamine-associated psychotic disorder: an internet based survey conducted in Turkey

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年1月4日

查看全文
  • Mehmet Hamdi Örüm,
  • Yaşar Kapıcı,
  • Doğancan Sönmez,
  • Ali Baran Tanrıkulu,
  • Merve Gümüşay,
  • Onur Koçhan,
  • Dilek Örüm,
  • Çiçek Hocaoğlu

摘要

Background

Many variables may affect approaches of psychiatrists to methamphetamine-associated psychotic disorder (MAP) treatment. This study was aimed to reach adult psychiatrists actively practicing in Turkey through an internet-based survey and to determine their practices and attitudes to MAP treatment.

Methods

In this internet-based study, participants were divided into three groups based on their answers: Those who do not follow-up any MAP patient were group 1 (n = 78), partially involved in the treatment process of at least one patient diagnosed with MAP were group 2 (n = 128), completely involved in the treatment process of at least one patient diagnosed with MAP were group 3 (n = 202).

Results

Psychotropic preferences in insomnia (p < 0.001), typical oral antipsychotic choice (p < 0.001), preferred doses of olanzapine/risperidone/aripiprazole/amisulpride for maintenance treatment (p < 0.001), long-acting injectable antipsychotic use practices (p < 0.001), non-antipsychotic psychotropic use characteristics (p < 0.001), extrapyramidal system side effect experiences (p < 0.001), delirium and life-threatening situations encounter rates (p < 0.001) were significantly different between group 2 and group 3. While the duration of maintenance with antipsychotics in the first MAP episode was similar between group 2 and group 3 (p = 0.254), it was different in the second and subsequent MAP episodes (p < 0.05). A binary logistic regression model containing the experiences of long-acting injectable antipsychotic use, extrapyramidal system side effect, and delirium was created (overall p < 0.001, Nagelkerke R2 = 0.435; Hosmer and Lemeshow test p = 0.203).

Conclusions

This first study in the field, which examines the current issue in detail, reveals that there are many factors that seriously affect psychiatrists' approaches to MAP treatment in Turkey.

Trial registration

This study was approved by the Ethics Committee of the Fırat University (Date: 14/09/2023; Number: 2023/12–12).